Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Obstetric Anesthesia|August 24, 2004
Bupivacaine 2.5 mg/ml versus bupivacaine 0.625 mg/ml and sufentanil l microg/ml with or without epinephrine 1 microg/ml for epidural analgesia in labourV Dahl, I Hagen, K S Koss, et al.
Anticancer Research|March 12, 1998
Comparison of extracellular matrix in human osteosarcomas and melanomas growing as xenografts, multicellular spheroids, and monolayer culturesC D Davies, H Müller, I Hagen, et al.
Thrombosis Research|July 1, 1982
Demonstration of variable forms of the platelet factor 4 immunoprecipitate using crossed immunoelectrophoresisI Hagen, F Brosstad, G O Gogstad, et al.
Biochimica Et Biophysica Acta|March 23, 1983
Demonstration of a new glycoprotein Ib-related component in platelet extracts prepared in the presence of leupeptinN O Solum, T M Olsen, G O Gogstad, et al.
International Angiology : a Journal of the International Union of Angiology|September 20, 2012
Surgery for ruptured abdominal aortic aneurysm and early mortality in women. Risk factors and complication profileC Berge, A I Hagen, H O Myhre, et al.
The Science of the Total Environment|August 1, 1988
Impact of bleached kraft mill effluents on drinking water qualityB Wigilius, H Borén, A Grimvall, et al.
Journal of Cancer Survivorship : Research and Practice|November 22, 2024
Digital goal management training for cognitive impairment in cervical cancer survivors-a randomized comparison studyE W Areklett, B I Hagen, J Stubberud, et al.
Scandinavian Journal of Haematology|September 1, 1978
A syndrome of factor VII deficiency and abnormal platelet release reactionB Ly, N O Solum, A M Vennerød, et al.
BJS Open|March 25, 2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trialK Ausen, A I Hagen, H S Østbyhaug, et al.
Brain, Behavior, & Immunity - Health|June 19, 2026
Subjective and objective working memory deficits in the post-acute phase of COVID-19 in a clinical trial populationSofie Buer, Bjørn I Hagen, Arne Søraas, et al.
Pageof 6